Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 July 2002:
Vol. 297. no. 5580, pp. 353 - 356
DOI: 10.1126/science.1072994
Prev | Table of Contents | Next

Review

The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

John Hardy,1 Dennis J. Selkoe2*

It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid beta -peptide (Abeta ) in plaques in brain tissue. According to the amyloid hypothesis, accumulation of Abeta in the brain is the primary influence driving AD pathogenesis. The rest of the disease process, including formation of neurofibrillary tangles containing tau protein, is proposed to result from an imbalance between Abeta production and Abeta clearance.

1 Laboratories of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA.
2 Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.
*   To whom correspondence should be addressed. E-mail: selkoe{at}cnd.bwh.harvard.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Angiotensin Receptor Blocker Prevented {beta}-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling.
S. Takeda, N. Sato, D. Takeuchi, H. Kurinami, M. Shinohara, K. Niisato, M. Kano, T. Ogihara, H. Rakugi, and R. Morishita (2009)
Hypertension 54, 1345-1352
   Abstract »    Full Text »    PDF »
Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid {beta}-Protein (A{beta}) Assembly from Alzheimer Disease Brains.
A. Noguchi, S. Matsumura, M. Dezawa, M. Tada, M. Yanazawa, A. Ito, M. Akioka, S. Kikuchi, M. Sato, S. Ideno, et al. (2009)
J. Biol. Chem. 284, 32895-32905
   Abstract »    Full Text »    PDF »
Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid-{beta}, Wild-Type Tau, and R406W Tau.
C. Tackenberg and R. Brandt (2009)
J. Neurosci. 29, 14439-14450
   Abstract »    Full Text »    PDF »
Cellular Prion Protein Mediates the Toxicity of {beta}-Amyloid Oligomers: Implications for Alzheimer Disease.
H. B. Nygaard and S. M. Strittmatter (2009)
Arch Neurol 66, 1325-1328
   Abstract »    Full Text »    PDF »
Presenilins Are Enriched in Endoplasmic Reticulum Membranes Associated with Mitochondria.
E. Area-Gomez, A. J.C. de Groof, I. Boldogh, T. D. Bird, G. E. Gibson, C. M. Koehler, W. H. Yu, K. E. Duff, M. P. Yaffe, L. A. Pon, et al. (2009)
Am. J. Pathol. 175, 1810-1816
   Abstract »    Full Text »    PDF »
Amyloid-Peptide Vaccinations Reduce {beta}-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer's Transgenic Mice.
B. Liu, S. Rasool, Z. Yang, C. G. Glabe, S. S. Schreiber, J. Ge, and Z. Tan (2009)
Am. J. Pathol. 175, 2099-2110
   Abstract »    Full Text »    PDF »
DNA {beta}-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model.
D. Lambracht-Washington, B.-X. Qu, M. Fu, T. N. Eagar, O. Stuve, and R. N. Rosenberg (2009)
JAMA 302, 1796-1802
   Abstract »    Full Text »    PDF »
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain.
K. Ghosal, D. L. Vogt, M. Liang, Y. Shen, B. T. Lamb, and S. W. Pimplikar (2009)
PNAS 106, 18367-18372
   Abstract »    Full Text »    PDF »
G Protein-Coupled Receptors, Cholinergic Dysfunction, and A{beta} Toxicity in Alzheimer's Disease.
A. Thathiah and B. De Strooper (2009)
Science Signaling 2, re8
   Abstract »    Full Text »    PDF »
Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway.
Z. V. Goodger, L. Rajendran, A. Trutzel, B. M. Kohli, R. M. Nitsch, and U. Konietzko (2009)
J. Cell Sci. 122, 3703-3714
   Abstract »    Full Text »    PDF »
Axonal Transport Defects in Neurodegenerative Diseases.
G. A. Morfini, M. Burns, L. I. Binder, N. M. Kanaan, N. LaPointe, D. A. Bosco, R. H. Brown Jr, H. Brown, A. Tiwari, L. Hayward, et al. (2009)
J. Neurosci. 29, 12776-12786
   Abstract »    Full Text »    PDF »
Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
N. M. Scheinin, S. Aalto, J. Koikkalainen, J. Lotjonen, M. Karrasch, N. Kemppainen, M. Viitanen, K. Nagren, S. Helin, M. Scheinin, et al. (2009)
Neurology 73, 1186-1192
   Abstract »    Full Text »    PDF »
Alzheimer's Disease Affects Progenitor Cells through Aberrant {beta}-Catenin Signaling.
M. A. Khan and L. Berti (2009)
J. Neurosci. 29, 12369-12371
   Full Text »    PDF »
Matrix Metalloprotease-9 Inhibition Improves Amyloid {beta}-Mediated Cognitive Impairment and Neurotoxicity in Mice.
H. Mizoguchi, K. Takuma, E. Fukuzaki, D. Ibi, E. Someya, K.-h. Akazawa, T. Alkam, H. Tsunekawa, A. Mouri, Y. Noda, et al. (2009)
J. Pharmacol. Exp. Ther. 331, 14-22
   Abstract »    Full Text »    PDF »
Prions: Protein Aggregation and Infectious Diseases.
A. Aguzzi and A. M. Calella (2009)
Physiol Rev 89, 1105-1152
   Abstract »    Full Text »    PDF »
Ten-Year Change in Plasma Amyloid {beta} Levels and Late-Life Cognitive Decline.
O. I. Okereke, W. Xia, D. J. Selkoe, and F. Grodstein (2009)
Arch Neurol 66, 1247-1253
   Abstract »    Full Text »    PDF »
Green Tea (-)-Epigallocatechin-3-Gallate Inhibits {beta}-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-{kappa}B Pathways in Mice.
J. W. Lee, Y. K. Lee, J. O. Ban, T. Y. Ha, Y. P. Yun, S. B. Han, K. W. Oh, and J. T. Hong (2009)
J. Nutr. 139, 1987-1993
   Abstract »    Full Text »    PDF »
Cognitive Deficit in Amyloid-{beta}-Injected Mice Was Improved by Pretreatment With a Low Dose of Telmisartan Partly Because of Peroxisome Proliferator-Activated Receptor-{gamma} Activation.
K. Tsukuda, M. Mogi, J. Iwanami, L.-J. Min, A. Sakata, F. Jing, M. Iwai, and M. Horiuchi (2009)
Hypertension 54, 782-787
   Abstract »    Full Text »    PDF »
Reversal of long-term dendritic spine alterations in Alzheimer disease models.
D. L. Smith, J. Pozueta, B. Gong, O. Arancio, and M. Shelanski (2009)
PNAS 106, 16877-16882
   Abstract »    Full Text »    PDF »
Glycosylation profiles of epitope-specific anti-{beta}-amyloid antibodies revealed by liquid chromatography-mass spectrometry.
I. Perdivara, L. J Deterding, C. Cozma, K. B Tomer, and M. Przybylski (2009)
Glycobiology 19, 958-970
   Abstract »    Full Text »    PDF »
Amino Acid Position-specific Contributions to Amyloid {beta}-Protein Oligomerization.
S. K. Maji, R. R. Ogorzalek Loo, M. Inayathullah, S. M. Spring, S. S. Vollers, M. M. Condron, G. Bitan, J. A. Loo, and D. B. Teplow (2009)
J. Biol. Chem. 284, 23580-23591
   Abstract »    Full Text »    PDF »
Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice.
P. Yan, A. W. Bero, J. R. Cirrito, Q. Xiao, X. Hu, Y. Wang, E. Gonzales, D. M. Holtzman, and J.-M. Lee (2009)
J. Neurosci. 29, 10706-10714
   Abstract »    Full Text »    PDF »
The Caenorhabditis elegans A{beta}1-42 Model of Alzheimer Disease Predominantly Expresses A{beta}3-42.
G. McColl, B. R. Roberts, A. P. Gunn, K. A. Perez, D. J. Tew, C. L. Masters, K. J. Barnham, R. A. Cherny, and A. I. Bush (2009)
J. Biol. Chem. 284, 22697-22702
   Abstract »    Full Text »    PDF »
AIP-1 ameliorates {beta}-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.
W. M. Hassan, D. A. Merin, V. Fonte, and C. D. Link (2009)
Hum. Mol. Genet. 18, 2739-2747
   Abstract »    Full Text »    PDF »
The Role of the p75 Neurotrophin Receptor in Cholinergic Dysfunction in Alzheimer's Disease.
E.J. Coulson, L.M. May, A.M. Sykes, and A.S. Hamlin (2009)
Neuroscientist 15, 317-323
   Abstract »    PDF »
Decreased Brain-Derived Neurotrophic Factor Depends on Amyloid Aggregation State in Transgenic Mouse Models of Alzheimer's Disease.
S. Peng, D. J. Garzon, M. Marchese, W. Klein, S. D. Ginsberg, B. M. Francis, H. T. J. Mount, E. J. Mufson, A. Salehi, and M. Fahnestock (2009)
J. Neurosci. 29, 9321-9329
   Abstract »    Full Text »    PDF »
Design of therapeutic proteins with enhanced stability.
N. Chennamsetty, V. Voynov, V. Kayser, B. Helk, and B. L. Trout (2009)
PNAS 106, 11937-11942
   Abstract »    Full Text »    PDF »
{beta}-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin.
Q.-L. Ma, F. Yang, E. R. Rosario, O. J. Ubeda, W. Beech, D. J. Gant, P. P. Chen, B. Hudspeth, C. Chen, Y. Zhao, et al. (2009)
J. Neurosci. 29, 9078-9089
   Abstract »    Full Text »    PDF »
Prostaglandin E2 Stimulates the Production of Amyloid-{beta} Peptides through Internalization of the EP4 Receptor.
T. Hoshino, T. Namba, M. Takehara, T. Nakaya, Y. Sugimoto, W. Araki, S. Narumiya, T. Suzuki, and T. Mizushima (2009)
J. Biol. Chem. 284, 18493-18502
   Abstract »    Full Text »    PDF »
Amyloid Reduction by Amyloid-{beta} Vaccination Also Reduces Mouse Tau Pathology and Protects from Neuron Loss in Two Mouse Models of Alzheimer's Disease.
D. M. Wilcock, N. Gharkholonarehe, W. E. Van Nostrand, J. Davis, M. P. Vitek, and C. A. Colton (2009)
J. Neurosci. 29, 7957-7965
   Abstract »    Full Text »    PDF »
The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology{diamondsuit}.
E. Podoly, D. E. Shalev, S. Shenhar-Tsarfaty, E. R. Bennett, E. Ben Assayag, H. Wilgus, O. Livnah, and H. Soreq (2009)
J. Biol. Chem. 284, 17170-17179
   Abstract »    Full Text »    PDF »
Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor {alpha}/WSX-1/gp130.
Y. Hashimoto, M. Kurita, S. Aiso, I. Nishimoto, and M. Matsuoka (2009)
Mol. Biol. Cell 20, 2864-2873
   Abstract »    Full Text »    PDF »
{alpha}-Helix targeting reduces amyloid-{beta} peptide toxicity.
C. Nerelius, A. Sandegren, H. Sargsyan, R. Raunak, H. Leijonmarck, U. Chatterjee, A. Fisahn, S. Imarisio, D. A. Lomas, D. C. Crowther, et al. (2009)
PNAS 106, 9191-9196
   Abstract »    Full Text »    PDF »
Conditional Forebrain Inactivation of Nicastrin Causes Progressive Memory Impairment and Age-Related Neurodegeneration.
K. Tabuchi, G. Chen, T. C. Sudhof, and J. Shen (2009)
J. Neurosci. 29, 7290-7301
   Abstract »    Full Text »    PDF »
Formation of Hirano Bodies after Inducible Expression of a Modified Form of an Actin-Cross-Linking Protein.
J. F. Reyes, K. Stone, J. Ramos, and A. Maselli (2009)
Eukaryot. Cell 8, 852-857
   Abstract »    Full Text »    PDF »
Seeded growth of {beta}-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure.
A. K. Paravastu, I. Qahwash, R. D. Leapman, S. C. Meredith, and R. Tycko (2009)
PNAS 106, 7443-7448
   Abstract »    Full Text »    PDF »
Nitric Oxide Links Mitochondrial Fission to Alzheimer's Disease.
B. Westermann (2009)
Science Signaling 2, pe29
   Abstract »    Full Text »    PDF »
Review: Therapy for Alzheimer's disease: how effective are current treatments?.
K. L. Lanctot, R. D. Rajaram, and N. Herrmann (2009)
Therapeutic Advances in Neurological Disorders 2, 163-180
   Abstract »    PDF »
Avoiding Unintended Toxicity.
T. E. Golde and T. L. Kukar (2009)
Science 324, 603-604
   Abstract »    Full Text »    PDF »
MMP-9 Sheds the {beta}2 Integrin Subunit (CD18) from Macrophages.
T. Vaisar, S. Y. Kassim, I. G. Gomez, P. S. Green, S. Hargarten, P. J. Gough, W. C. Parks, C. L. Wilson, E. W. Raines, and J. W. Heinecke (2009)
Mol. Cell. Proteomics 8, 1044-1060
   Abstract »    Full Text »    PDF »
Episodic memory loss is related to hippocampal-mediated {beta}-amyloid deposition in elderly subjects.
E. C. Mormino, J. T. Kluth, C. M. Madison, G. D. Rabinovici, S. L. Baker, B. L. Miller, R. A. Koeppe, C. A. Mathis, M. W. Weiner, W. J. Jagust, et al. (2009)
Brain 132, 1310-1323
   Abstract »    Full Text »    PDF »
A{beta}PP/APLP2 Family of Kunitz Serine Proteinase Inhibitors Regulate Cerebral Thrombosis.
F. Xu, M. L. Previti, M. T. Nieman, J. Davis, A. H. Schmaier, and W. E. Van Nostrand (2009)
J. Neurosci. 29, 5666-5670
   Abstract »    Full Text »    PDF »
Fibrillar amyloid-{beta} burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
E. M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu, W. Lee, N. Ayutyanont, J. Keppler, S. A. Reeder, J. B. S. Langbaum, et al. (2009)
PNAS 106, 6820-6825
   Abstract »    Full Text »    PDF »
Role and Therapeutic Potential of VEGF in the Nervous System.
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet (2009)
Physiol Rev 89, 607-648
   Abstract »    Full Text »    PDF »
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review.
L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone (2009)
American Journal of Alzheimer's Disease and Other Dementias 24, 95-121
   Abstract »    PDF »
Successful Versus Failed Adaptation to High-Fat Diet-Induced Insulin Resistance: The Role of IAPP-Induced {beta}-Cell Endoplasmic Reticulum Stress.
A. V. Matveyenko, T. Gurlo, M. Daval, A. E. Butler, and P. C. Butler (2009)
Diabetes 58, 906-916
   Abstract »    Full Text »    PDF »
Hyperhomocysteinemia Increases {beta}-Amyloid by Enhancing Expression of {gamma}-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain.
C.-E Zhang, W. Wei, Y.-H. Liu, J.-H. Peng, Q. Tian, G.-P. Liu, Y. Zhang, and J.-Z. Wang (2009)
Am. J. Pathol. 174, 1481-1491
   Abstract »    Full Text »    PDF »
Amyloid Goes Global.
I. Bezprozvanny (2009)
Science Signaling 2, pe16
   Abstract »    Full Text »    PDF »
Intracerebroventricular amyloid-{beta} antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.
D. R. Thakker, M. R. Weatherspoon, J. Harrison, T. E. Keene, D. S. Lane, W. F. Kaemmerer, G. R. Stewart, and L. L. Shafer (2009)
PNAS 106, 4501-4506
   Abstract »    Full Text »    PDF »
A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis.
G. Di Fede, M. Catania, M. Morbin, G. Rossi, S. Suardi, G. Mazzoleni, M. Merlin, A. R. Giovagnoli, S. Prioni, A. Erbetta, et al. (2009)
Science 323, 1473-1477
   Abstract »    Full Text »    PDF »
Different Patterns of Cerebral Injury in Dementia With or Without Diabetes.
J. A. Sonnen, E. B. Larson, K. Brickell, P. K. Crane, R. Woltjer, T. J. Montine, and S. Craft (2009)
Arch Neurol 66, 315-322
   Abstract »    Full Text »    PDF »
Amyloid {beta}-Protein Assembly and Alzheimer Disease.
R. Roychaudhuri, M. Yang, M. M. Hoshi, and D. B. Teplow (2009)
J. Biol. Chem. 284, 4749-4753
   Full Text »    PDF »
Neural Stem Cells and Alzheimer's Disease: Challenges and Hope.
Zhongling Feng, Gang Zhao, and Lei Yu (2009)
American Journal of Alzheimer's Disease and Other Dementias 24, 52-57
   Abstract »    PDF »
O-Mannosylation is required for the solubilization of heterologously expressed human beta-amyloid precursor protein in Saccharomyces cerevisiae..
A. Murakami-Sekimata, K. Sato, K. Sato, A. Takashima, and A. Nakano (2009)
Genes Cells 14, 205-215
   Abstract »    Full Text »    PDF »
Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology.
J. K. Ryu, T. Cho, H. B. Choi, Y. T. Wang, and J. G. McLarnon (2009)
J. Neurosci. 29, 3-13
   Abstract »    Full Text »    PDF »
Do amyloid-lowering strategies work clinically?.
R. J. van Marum (2009)
Therapeutic Advances in Neurological Disorders 2, 3-6
   PDF »
Alzheimer disease: Time to improve its diagnosis and treatment.
S. SALLOWAY and S. CORREIA (2009)
Cleveland Clinic Journal of Medicine 76, 49-58
   Abstract »    Full Text »    PDF »
The Role of the Immune System in Alzheimer's Disease.
R. M. Cohen (2009)
Focus 7, 28-35
   Abstract »    Full Text »    PDF »
First Demonstration of Cerebrospinal Fluid and Plasma A{beta} Lowering with Oral Administration of a {beta}-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates.
S. Sankaranarayanan, M. A. Holahan, D. Colussi, M.-C. Crouthamel, V. Devanarayan, J. Ellis, A. Espeseth, A. T. Gates, S. L. Graham, A. R. Gregro, et al. (2009)
J. Pharmacol. Exp. Ther. 328, 131-140
   Abstract »    Full Text »    PDF »
Amyloid-{beta} overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins.
X. Wang, B. Su, S. L. Siedlak, P. I. Moreira, H. Fujioka, Y. Wang, G. Casadesus, and X. Zhu (2008)
PNAS 105, 19318-19323
   Abstract »    Full Text »    PDF »
Consequence of A{beta} immunization on the vasculature of human Alzheimer's disease brain.
D. Boche, E. Zotova, R. O. Weller, S. Love, J. W. Neal, R. M. Pickering, D. Wilkinson, C. Holmes, and J. A. R. Nicoll (2008)
Brain 131, 3299-3310
   Abstract »    Full Text »    PDF »
Blocking A{beta}42 Accumulation Delays the Onset and Progression of Tau Pathology via the C Terminus of Heat Shock Protein70-Interacting Protein: A Mechanistic Link between A{beta} and Tau Pathology.
S. Oddo, A. Caccamo, B. Tseng, D. Cheng, V. Vasilevko, D. H. Cribbs, and F. M. LaFerla (2008)
J. Neurosci. 28, 12163-12175
   Abstract »    Full Text »    PDF »
Sequestration of Copper from {beta}-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents.
W.-h. Wu, P. Lei, Q. Liu, J. Hu, A. P. Gunn, M.-s. Chen, Y.-f. Rui, X.-y. Su, Z.-p. Xie, Y.-F. Zhao, et al. (2008)
J. Biol. Chem. 283, 31657-31664
   Abstract »    Full Text »    PDF »
Dynamics of A{beta} Turnover and Deposition in Different {beta}-Amyloid Precursor Protein Transgenic Mouse Models Following {gamma}-Secretase Inhibition.
D. Abramowski, K.-H. Wiederhold, U. Furrer, A.-L. Jaton, A. Neuenschwander, M.-J. Runser, S. Danner, J. Reichwald, D. Ammaturo, D. Staab, et al. (2008)
J. Pharmacol. Exp. Ther. 327, 411-424
   Abstract »    Full Text »    PDF »
IL-4-Induced Selective Clearance of Oligomeric {beta}-Amyloid Peptide1-42 by Rat Primary Type 2 Microglia.
E. Shimizu, K. Kawahara, M. Kajizono, M. Sawada, and H. Nakayama (2008)
J. Immunol. 181, 6503-6513
   Abstract »    Full Text »    PDF »
Intramembrane Proteolysis by {gamma}-Secretase.
H. Steiner, R. Fluhrer, and C. Haass (2008)
J. Biol. Chem. 283, 29627-29631
   Abstract »    Full Text »    PDF »
Structural Classification of Toxic Amyloid Oligomers.
C. G. Glabe (2008)
J. Biol. Chem. 283, 29639-29643
   Abstract »    Full Text »    PDF »
Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats.
C. K. Jones, A. E. Brady, A. A. Davis, Z. Xiang, M. Bubser, M. N. Tantawy, A. S. Kane, T. M. Bridges, J. P. Kennedy, S. R. Bradley, et al. (2008)
J. Neurosci. 28, 10422-10433
   Abstract »    Full Text »    PDF »
Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease.
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al. (2008)
J. Pharmacol. Exp. Ther. 326, 739-744
   Abstract »    Full Text »    PDF »
BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus.
H. Wang, L. Song, F. Laird, P. C. Wong, and H.-K. Lee (2008)
J. Neurosci. 28, 8677-8681
   Abstract »    Full Text »    PDF »
Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: Deficit in memory retrieval associated with increased sensitivity to interference?.
S. Daumas, J. Sandin, K. S. Chen, D. Kobayashi, J. Tulloch, S. J. Martin, D. Games, and R. G.M. Morris (2008)
Learn. Mem. 15, 625-632
   Abstract »    Full Text »    PDF »
The Amyloid-{beta} Rise and {gamma}-Secretase Inhibitor Potency Depend on the Level of Substrate Expression.
C. R. Burton, J. E. Meredith, D. M. Barten, M. E. Goldstein, C. M. Krause, C. J. Kieras, L. Sisk, L. G. Iben, C. Polson, M. W. Thompson, et al. (2008)
J. Biol. Chem. 283, 22992-23003
   Abstract »    Full Text »    PDF »
Presenilins: Members of the {gamma}-Secretase Quartets, But Part-Time Soloists Too.
T. Wakabayashi and B. De Strooper (2008)
Physiology 23, 194-204
   Abstract »    Full Text »    PDF »
Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach.
D. Han-Xiang, J. Hujun, F. Ronggen, Z. Hong, S. Yong, L. Erdong, H. Makito, C. D. C. Mauro, and S. Teepu (2008)
Hum. Mol. Genet. 17, 2310-2319
   Abstract »    Full Text »    PDF »
Glu332 in the Nicastrin Ectodomain Is Essential for {gamma}-Secretase Complex Maturation but Not for Its Activity.
L. Chavez-Gutierrez, A. Tolia, E. Maes, T. Li, P. C. Wong, and B. de Strooper (2008)
J. Biol. Chem. 283, 20096-20105
   Abstract »    Full Text »    PDF »
Abeta Predictor of Alzheimer Disease Symptoms.
C. F. Sephton and G. Yu (2008)
Arch Neurol 65, 875-876
   Full Text »    PDF »
Distinct Pools of {beta}-Amyloid in Alzheimer Disease-Affected Brain: A Clinicopathologic Study.
J. R. Steinerman, M. Irizarry, N. Scarmeas, S. Raju, J. Brandt, M. Albert, D. Blacker, B. Hyman, and Y. Stern (2008)
Arch Neurol 65, 906-912
   Abstract »    Full Text »    PDF »
Grape-Derived Polyphenolics Prevent A{beta} Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease.
J. Wang, L. Ho, W. Zhao, K. Ono, C. Rosensweig, L. Chen, N. Humala, D. B. Teplow, and G. M. Pasinetti (2008)
J. Neurosci. 28, 6388-6392
   Abstract »    Full Text »    PDF »
Protein Kinase C{epsilon} Binds Peripherin and Induces Its Aggregation, Which Is Accompanied by Apoptosis of Neuroblastoma Cells.
L. Sunesson, U. Hellman, and C. Larsson (2008)
J. Biol. Chem. 283, 16653-16664
   Abstract »    Full Text »    PDF »
Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid {beta} Protein Production.
H. Shimizu, A. Tosaki, K. Kaneko, T. Hisano, T. Sakurai, and N. Nukina (2008)
Mol. Cell. Biol. 28, 3663-3671
   Abstract »    Full Text »    PDF »
Neurogenesis and Alterations of Neural Stem Cells in Mouse Models of Cerebral Amyloidosis.
F. V. Ermini, S. Grathwohl, R. Radde, M. Yamaguchi, M. Staufenbiel, T. D. Palmer, and M. Jucker (2008)
Am. J. Pathol. 172, 1520-1528
   Abstract »    Full Text »    PDF »
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid {beta}1-42 and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease.
K. L. Richard, M. Filali, P. Prefontaine, and S. Rivest (2008)
J. Neurosci. 28, 5784-5793
   Abstract »    Full Text »    PDF »
Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis: Aspects of a Protein Quality Disease.
J. Herrmann, S. M. Soares, L. O. Lerman, and A. Lerman (2008)
J. Am. Coll. Cardiol. 51, 2003-2010
   Abstract »    Full Text »    PDF »
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and A{beta} accumulation.
A. Muhammad, I. Flores, H. Zhang, R. Yu, A. Staniszewski, E. Planel, M. Herman, L. Ho, R. Kreber, L. S. Honig, et al. (2008)
PNAS 105, 7327-7332
   Abstract »    Full Text »    PDF »
Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice.
F. Xu, M. P. Vitek, C. A. Colton, M. L. Previti, N. Gharkholonarehe, J. Davis, and W. E. Van Nostrand (2008)
J. Neurosci. 28, 5312-5320
   Abstract »    Full Text »    PDF »
Platinum-based inhibitors of amyloid-{beta} as therapeutic agents for Alzheimer's disease.
K. J. Barnham, V. B. Kenche, G. D. Ciccotosto, D. P. Smith, D. J. Tew, X. Liu, K. Perez, G. A. Cranston, T. J. Johanssen, I. Volitakis, et al. (2008)
PNAS 105, 6813-6818
   Abstract »    Full Text »    PDF »
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis.
L. Haataja, T. Gurlo, C. J. Huang, and P. C. Butler (2008)
Endocr. Rev. 29, 303-316
   Abstract »    Full Text »    PDF »
Role of Insulin Metabolism Disturbances in the Development of Alzheimer Disease: Mini Review.
B. Sabayan, F. Foroughinia, A. Mowla, and A. Borhanihaghighi (2008)
American Journal of Alzheimer's Disease and Other Dementias 23, 192-199
   Abstract »    PDF »
Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits.
H. Belinson, D. Lev, E. Masliah, and D. M. Michaelson (2008)
J. Neurosci. 28, 4690-4701
   Abstract »    Full Text »    PDF »
Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance.
T. Bolmont, F. Haiss, D. Eicke, R. Radde, C. A. Mathis, W. E. Klunk, S. Kohsaka, M. Jucker, and M. E. Calhoun (2008)
J. Neurosci. 28, 4283-4292
   Abstract »    Full Text »    PDF »
{beta}-Amyloid1-42 Induces Neuronal Death through the p75 Neurotrophin Receptor.
A. Sotthibundhu, A. M. Sykes, B. Fox, C. K. Underwood, W. Thangnipon, and E. J. Coulson (2008)
J. Neurosci. 28, 3941-3946
   Abstract »    Full Text »    PDF »
Stabilization of a {beta}-hairpin in monomeric Alzheimer's amyloid-{beta} peptide inhibits amyloid formation.
W. Hoyer, C. Gronwall, A. Jonsson, S. Stahl, and T. Hard (2008)
PNAS 105, 5099-5104
   Abstract »    Full Text »    PDF »
Characterization of Cullin-box Sequences That Direct Recruitment of Cul2-Rbx1 and Cul5-Rbx2 Modules to Elongin BC-based Ubiquitin Ligases.
N. Mahrour, W. B. Redwine, L. Florens, S. K. Swanson, S. Martin-Brown, W. D. Bradford, K. Staehling-Hampton, M. P. Washburn, R. C. Conaway, and J. W. Conaway (2008)
J. Biol. Chem. 283, 8005-8013
   Abstract »    Full Text »    PDF »
Lack of Pathology in a Triple Transgenic Mouse Model of Alzheimer's Disease after Overexpression of the Anti-Apoptotic Protein Bcl-2.
T. T. Rohn, V. Vyas, T. Hernandez-Estrada, K. E. Nichol, L.-A. Christie, and E. Head (2008)
J. Neurosci. 28, 3051-3059
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)